Logo image of FONR

FONAR CORP (FONR) Stock Fundamental Analysis

NASDAQ:FONR - Nasdaq - US3444374058 - Common Stock - Currency: USD

12.3  -0.25 (-1.99%)

After market: 12.3 0 (0%)

Fundamental Rating

5

Overall FONR gets a fundamental rating of 5 out of 10. We evaluated FONR against 189 industry peers in the Health Care Equipment & Supplies industry. FONR is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. FONR has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year FONR was profitable.
In the past year FONR had a positive cash flow from operations.
Each year in the past 5 years FONR has been profitable.
Each year in the past 5 years FONR had a positive operating cash flow.
FONR Yearly Net Income VS EBIT VS OCF VS FCFFONR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

1.2 Ratios

With an excellent Return On Assets value of 3.52%, FONR belongs to the best of the industry, outperforming 80.42% of the companies in the same industry.
FONR has a better Return On Equity (4.31%) than 77.25% of its industry peers.
With a decent Return On Invested Capital value of 4.66%, FONR is doing good in the industry, outperforming 78.31% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for FONR is in line with the industry average of 7.71%.
Industry RankSector Rank
ROA 3.52%
ROE 4.31%
ROIC 4.66%
ROA(3y)4.96%
ROA(5y)4.84%
ROE(3y)6.44%
ROE(5y)6.47%
ROIC(3y)7.14%
ROIC(5y)7.07%
FONR Yearly ROA, ROE, ROICFONR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With an excellent Profit Margin value of 7.20%, FONR belongs to the best of the industry, outperforming 80.42% of the companies in the same industry.
In the last couple of years the Profit Margin of FONR has declined.
FONR's Operating Margin of 11.93% is fine compared to the rest of the industry. FONR outperforms 78.84% of its industry peers.
In the last couple of years the Operating Margin of FONR has declined.
Looking at the Gross Margin, with a value of 41.48%, FONR is doing worse than 67.72% of the companies in the same industry.
FONR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.93%
PM (TTM) 7.2%
GM 41.48%
OM growth 3Y-5.46%
OM growth 5Y-8.71%
PM growth 3Y-3.38%
PM growth 5Y-10.22%
GM growth 3Y-3.21%
GM growth 5Y-2.4%
FONR Yearly Profit, Operating, Gross MarginsFONR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FONR is destroying value.
Compared to 1 year ago, FONR has less shares outstanding
Compared to 5 years ago, FONR has about the same amount of shares outstanding.
Compared to 1 year ago, FONR has an improved debt to assets ratio.
FONR Yearly Shares OutstandingFONR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
FONR Yearly Total Debt VS Total AssetsFONR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 2.60 indicates that FONR is not a great score, but indicates only limited risk for bankruptcy at the moment.
FONR has a Altman-Z score of 2.60. This is in the better half of the industry: FONR outperforms 66.67% of its industry peers.
FONR has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.
FONR has a better Debt to FCF ratio (0.07) than 94.71% of its industry peers.
FONR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of FONR (0.00) is better than 68.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Altman-Z 2.6
ROIC/WACC0.53
WACC8.81%
FONR Yearly LT Debt VS Equity VS FCFFONR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

A Current Ratio of 11.24 indicates that FONR has no problem at all paying its short term obligations.
With an excellent Current ratio value of 11.24, FONR belongs to the best of the industry, outperforming 94.18% of the companies in the same industry.
FONR has a Quick Ratio of 11.01. This indicates that FONR is financially healthy and has no problem in meeting its short term obligations.
FONR has a better Quick ratio (11.01) than 95.77% of its industry peers.
Industry RankSector Rank
Current Ratio 11.24
Quick Ratio 11.01
FONR Yearly Current Assets VS Current LiabilitesFONR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

1

3. Growth

3.1 Past

The earnings per share for FONR have decreased strongly by -38.52% in the last year.
The Earnings Per Share has been decreasing by -7.12% on average over the past years.
Looking at the last year, FONR shows a decrease in Revenue. The Revenue has decreased by -0.83% in the last year.
The Revenue has been growing slightly by 3.36% on average over the past years.
EPS 1Y (TTM)-38.52%
EPS 3Y1.78%
EPS 5Y-7.12%
EPS Q2Q%-46.78%
Revenue 1Y (TTM)-0.83%
Revenue growth 3Y4.6%
Revenue growth 5Y3.36%
Sales Q2Q%-1.72%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FONR Yearly Revenue VS EstimatesFONR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.50, the valuation of FONR can be described as very reasonable.
92.06% of the companies in the same industry are more expensive than FONR, based on the Price/Earnings ratio.
FONR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.85.
Industry RankSector Rank
PE 11.5
Fwd PE N/A
FONR Price Earnings VS Forward Price EarningsFONR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

FONR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. FONR is cheaper than 98.94% of the companies in the same industry.
FONR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. FONR is cheaper than 96.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.6
EV/EBITDA 1.4
FONR Per share dataFONR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The decent profitability rating of FONR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FONR!.
Industry RankSector Rank
Dividend Yield N/A

FONAR CORP

NASDAQ:FONR (5/1/2025, 9:02:47 PM)

After market: 12.3 0 (0%)

12.3

-0.25 (-1.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-17 2025-02-17
Earnings (Next)05-19 2025-05-19
Inst Owners49.73%
Inst Owner Change-0.51%
Ins Owners2.2%
Ins Owner Change0%
Market Cap77.98M
Analysts0
Price TargetN/A
Short Float %0.28%
Short Ratio1.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.5
Fwd PE N/A
P/S 0.77
P/FCF 9.6
P/OCF 6.9
P/B 0.46
P/tB 0.48
EV/EBITDA 1.4
EPS(TTM)1.07
EY8.7%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.28
FCFY10.41%
OCF(TTM)1.78
OCFY14.49%
SpS16.02
BVpS26.79
TBVpS25.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.52%
ROE 4.31%
ROCE 6.19%
ROIC 4.66%
ROICexc 6.42%
ROICexgc 6.78%
OM 11.93%
PM (TTM) 7.2%
GM 41.48%
FCFM 7.99%
ROA(3y)4.96%
ROA(5y)4.84%
ROE(3y)6.44%
ROE(5y)6.47%
ROIC(3y)7.14%
ROIC(5y)7.07%
ROICexc(3y)9.85%
ROICexc(5y)9.62%
ROICexgc(3y)10.45%
ROICexgc(5y)10.24%
ROCE(3y)9.49%
ROCE(5y)9.41%
ROICexcg growth 3Y-5.28%
ROICexcg growth 5Y-14.37%
ROICexc growth 3Y-4.76%
ROICexc growth 5Y-13.51%
OM growth 3Y-5.46%
OM growth 5Y-8.71%
PM growth 3Y-3.38%
PM growth 5Y-10.22%
GM growth 3Y-3.21%
GM growth 5Y-2.4%
F-Score6
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Debt/EBITDA 0.02
Cap/Depr 47.9%
Cap/Sales 3.13%
Interest Coverage 367.29
Cash Conversion 60.23%
Profit Quality 111.04%
Current Ratio 11.24
Quick Ratio 11.01
Altman-Z 2.6
F-Score6
WACC8.81%
ROIC/WACC0.53
Cap/Depr(3y)68.94%
Cap/Depr(5y)98.58%
Cap/Sales(3y)3.32%
Cap/Sales(5y)4.6%
Profit Quality(3y)113.41%
Profit Quality(5y)133.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-38.52%
EPS 3Y1.78%
EPS 5Y-7.12%
EPS Q2Q%-46.78%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.83%
Revenue growth 3Y4.6%
Revenue growth 5Y3.36%
Sales Q2Q%-1.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33.05%
EBIT growth 3Y-1.11%
EBIT growth 5Y-5.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-28.96%
FCF growth 3Y-4.82%
FCF growth 5Y-3.64%
OCF growth 1Y-26.41%
OCF growth 3Y-9.62%
OCF growth 5Y-6.24%